Neurology clinical trials recruiting in California

217 recruiting neurology trials match in California. Showing 20.

• A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Recruiting

  Phase 3 · Merck Sharp & Dohme LLC · Burbank, California

• STXBP1 and SYNGAP1 Related Disorders Natural History StudyRecruiting

  N/A · Children's Hospital of Philadelphia · Palo Alto, California

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)Recruiting

  N/A · TG Therapeutics, Inc. · Fresno, California

• A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic TherapyRecruiting

  Phase 2 · Vima Therapeutics · Farmington Hills, Michigan

• Alzheimer's Tau Platform: Master ProtocolRecruiting

  Phase 2 · Paul S. Aisen · San Francisco, California

• Treatment of Meniere's Disease With Migraine MedicationsRecruiting

  Phase 4 · University of California, Irvine · Orange, California

• Treatment of Participants With Primary or Secondary Progressive Multiple SclerosisRecruiting

  Phase 1 / Phase 2 · Tr1X, Inc. · La Jolla, California

• Treatment of Refractory Infantile Spasms With FenfluramineRecruiting

  Phase 2 · Children's Hospital of Orange County · Orange, California

• Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental StatesRecruiting

  N/A · University of Southern California · Downey, California

• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1Recruiting

  Phase 3 · Rapport Therapeutics Inc. · Palmdale, California

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresRecruiting

  Phase 3 · Xenon Pharmaceuticals Inc. · Los Angeles, California

• Epilepsy Learning Healthcare System (ELHS)Recruiting

  N/A · Epilepsy Foundation of America · Los Angeles, California

• Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)Recruiting

  Phase 3 · AbbVie · Anaheim, California

• Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersRecruiting

  Phase 1 / Phase 2 · Ashvattha Therapeutics, Inc. · San Francisco, California

• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric SubjectsRecruiting

  Phase 3 · Pfizer · Hawthorne, California

• TSC Biosample Repository and Natural History DatabaseRecruiting

  N/A · National Tuberous Sclerosis Association · Loma Linda, California

• Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Recruiting

  Phase 3 · Novartis Pharmaceuticals · Irvine, California

• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeRecruiting

  Phase 3 · Stoke Therapeutics, Inc · Beijing

• Deep Brain Stimulation (DBS) Retrospective Outcomes StudyRecruiting

  N/A · Boston Scientific Corporation · Moreno Valley, California

• Model-based Electrical Brain StimulationRecruiting

  N/A · University of Southern California · Los Angeles, California

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.